Massimiliano Bonifacio

71PUBLICATIONS
229CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Adolescent healthHaematological tumoursMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (71)

|Oct 14, 2026
Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

|Sep 08, 2026
Clinical Outcomes of Younger Adults With Philadelphia-Negative Acute Lymphoblastic Leukemia, Treated With A Pediatric-Like Regimen Based on the GIMEMA LAL1308 Protocol. A Campus ALL Study.

|Jul 22, 2026
Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network.

|May 27, 2026
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project.

|Mar 25, 2026
Clinical Outcomes of Ruxolitinib Treatment in Patients With IPSS Intermediate-1-Risk Myelofibrosis: Interim Analysis From an Italian, Prospective Study (ROMEI).

Paola Guglielmelli, Massimo Breccia, Francesco Mendicino

|Feb 13, 2026
Survival and quality-of-life implications of cytopenia trajectories in ruxolitinib-treated myelofibrosis.

Francesca Palandri, Giovanni Caocci, Elisabetta Abruzzese

Pageof 12

Frequent Collaborators

28 joint publications

Mario Tiribelli

27 joint publications

Alessandra Iurlo

26 joint publications

Massimo Breccia

22 joint publications

Elisabetta Abruzzese